Blood Collection Market to Grow at 7.9% CAGR, Driven by Technological Advancements

The Blood Collection Market is expected to grow significantly, reaching approximately USD 25.9 billion by 2033, up from USD 12.1 billion in 2023, with a Compound Annual Growth Rate (CAGR) of 7.9% during the forecast period from 2024 to 2033. This growth is driven by several factors including the increasing prevalence of infectious and chronic diseases, which heightens the demand for diagnostic testing. For instance, the rising incidence of tuberculosis and sickle cell anemia has significantly boosted the need for blood collection and transfusions.

Technological advancements in blood collection methods, such as the development of automated blood collection devices, are also contributing to market expansion. Companies like Vitestro have introduced innovative products combining AI and robotic technologies to enhance the efficiency and safety of blood collection procedures. Additionally, the widespread adoption of manual blood collection methods in hospitals and diagnostic centers underscores their critical role in patient care and diagnostics, capturing a substantial market share.

Challenges in the market include the high costs associated with automated blood collection devices and complexities related to the storage and transportation of collected blood. Furthermore, the market faces issues such as blood contamination risks and a shortage of skilled professionals to perform blood collection procedures.

Recent developments in the market include the launch of new blood collection devices and strategic collaborations among key players to expand their market presence and enhance their product offerings. For example, Owen Mumford and Q² Solutions have recently introduced advanced blood collection products and services, underscoring the continuous innovation within the industry.

Key Takeaways

• The Blood Collection Market is projected to reach USD 25.9 billion by 2033, growing at a robust CAGR of 7.9% from 2024 to 2033.
• In 2023, the venous segment dominates the market with a 79% share, thanks to versatile tools like double-ended needles and winged sets.
• The diagnostics segment leads in 2023, capturing over 67.6% of the market share, underscoring blood collection’s importance in healthcare diagnostics.
• Manual blood collection is preferred, holding a substantial 74.5% market share in 2023.
• Hospitals are the primary end-users, dominating with a market share of over 35.8% in 2023.
• North America leads the market with a 39.7% share in 2023, valued at USD 4.8 billion.

Get Sample PDF Report: https://market.us/report/blood-collection-market/request-sample/

Blood Collection Market Key Segments

Collection Site

Venous

• Needles and Syringes
  • Double-Ended Needles
  • Winged Blood Collection Sets
  • Standard Hypodermic Needles
  • Other Blood Collection Needles
• Blood Collection Tubes
  • Serum-separating
  • EDTA
  • Heparin
  • Plasma-separating
• Blood Bags
• Others

Capillary

• Lancets
• Micro-Container Tubes
• Micro-Hematocrit Tubes
• Warming Devices
• Others

Application

• Diagnostics
• Treatment

Method

• Manual Blood Collection
• Automated Blood Collection

End-use

• Hospitals
• Diagnostics Centers
• Blood Banks
• Emergency Departments
• Others

Key Regions

• North America (The US, Canada, Mexico)
• Western Europe (Germany, France, The UK, Spain, Italy, Portugal, Ireland, Austria, Switzerland, Benelux, Nordic, Rest of Western Europe)
• Eastern Europe (Russia, Poland, The Czech Republic, Greece, Rest of Eastern Europe)
• APAC (China, Japan, South Korea, India, Australia & New Zealand, Indonesia, Malaysia, Philippines, Singapore, Thailand, Vietnam, Rest of APAC)
• Latin America (Brazil, Colombia, Chile, Argentina, Costa Rica, Rest of Latin America)
• Middle East & Africa (Algeria, Egypt, Israel, Kuwait, Nigeria, Saudi Arabia, South Africa, Turkey, United Arab Emirates, Rest of MEA)

Buy Directly: https://market.us/purchase-report/?report_id=22535

Key Players Analysis

Abbott Laboratories is a leader in the blood collection sector, emphasizing innovations in diagnostics and medical devices. Abbott’s Alinity system and other diagnostics tools contribute significantly to efficient blood testing and collection. The company focuses on integrating advanced technologies to improve diagnostic accuracy and patient outcomes, addressing the needs of global healthcare markets. Abbott’s comprehensive approach includes developing user-friendly and efficient blood collection systems to streamline laboratory operations and ensure high-quality patient care​​.

Sarstedt AG specializes in the development and manufacturing of laboratory and medical equipment, including blood collection systems. The company is known for its comprehensive range of blood collection tubes, needles, and safety systems designed to enhance sample integrity and user safety. Sarstedt’s innovative products, such as the S-Monovette blood collection system, are widely used in clinical laboratories, emphasizing ease of use, contamination prevention, and accurate sample collection​.

NIPRO Medical Corp. is a global healthcare company known for its high-quality blood collection products, including needles, lancets, and blood collection tubes. NIPRO focuses on providing safe and reliable blood collection solutions to enhance patient comfort and safety. The company’s products are designed to meet rigorous clinical standards, ensuring precise and efficient blood sample collection for diagnostic purposes. NIPRO’s commitment to innovation and quality makes it a trusted name in the blood collection industry​​.

BD is a prominent player in the blood collection sector, offering a wide range of products including Vacutainer blood collection tubes, needles, and safety-engineered devices. BD focuses on improving the blood collection process through innovative technologies that enhance safety, efficiency, and patient comfort. The company’s commitment to advancing healthcare is evident in its continuous development of new products that address the evolving needs of clinical laboratories and healthcare providers​​.

Terumo Corp. is renowned for its advanced blood collection and processing systems. The company’s VACUETTE blood collection products are designed to ensure high-quality sample collection with minimal patient discomfort. Terumo emphasizes safety and efficiency in its product design, incorporating features that prevent contamination and ensure accurate diagnostic results. The company’s innovative approach and dedication to quality make it a key player in the global blood collection market​.

Blood Collection Market Key Players:

• Abbott Laboratories
• Sarstedt AG
• NIPRO Medical Corp.
• BD
• Terumo Corp.
• Medtronic Plc
• Qiagen NV
• FL Medical s.r.l.
• Greiner Holding AG
• Haemonetics Corp.

Blood Collection Market Report Scope >> Market Value (2023): USD 12.1 Billion || Forecast Revenue (2033): USD 25.9 Billion || CAGR (2024-2033): 7.9% || Base Year Estimation: 2023 || Historic Period: 2019-2022 || Forecast Period: 2024-2033.

Inquire More about report: https://market.us/report/blood-collection-market/#inquiry

About Market.US

Market.US is renowned for its comprehensive market research and analysis, providing customized and syndicated reports to a global clientele. Specializing in a variety of sectors, they offer strategic insights and detailed market forecasts, assisting businesses in making informed decisions. With a focus on innovation and accuracy, Market.US supports clients in over 126 countries, and maintains a strong repeat customer rate, underscoring their commitment to quality and client satisfaction. Their team excels in delivering exceptional research services, ensuring that no detail is overlooked in any target market.

Contact Details
Market.us (Powered By Prudour Pvt. Ltd.)
Contact No: +1 718 618 4351.
Email: inquiry@market.us
Blog: https://medicalmarketreport.com/

View More Trending Reports

AI In Life Science Market at USD 11.38 Billion by 2033

Antacids Market to Witness Significant Growth, Forecasted Value Reaches USD 10.2 Billion by 2033

Allogeneic Cell Therapy Devices Market Flourishes, Expected to Reach USD 3422.6 Million by 2033

Hepatitis D Market Emerges: Forecast Values Reach USD 1.0 Billion by 2033

Lung Disease Therapeutics Market Soars to USD 163.1 Billion by 2033